Researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.
Click here for original story, Genetic testing cost effective for newly diagnosed GIST
Source: ScienceDaily